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Transcoronary ethanol ablation (TCEA) for ventricular
tachycardia (VT) is a treatment option for selected patients
when endocardial and epicardial ablation have failed. We
present a case of successful TCEA for treatment of nearly
incessant VT in a patient in whom access to the left ventricle
(LV) was impeded because of prosthetic double valve
replacement.Case report
A 52-year-old man was referred for treatment of recurrent
sustained monomorphic VT with variable cycle lengths
(CLs) of 360 to 480 ms (125–166 bpm) causing recurrent
implantable cardioverter-deﬁbrillator (ICD) shocks despite
increasing doses of amiodarone. He had rheumatic heart
disease and had undergone mitral and aortic valve replace-
ments with mechanical St. Jude prostheses as well as
tricuspid valve repair 14 years previously. Two years after
surgery, he had an embolic lateral wall myocardial infarction
and subsequently developed recurrent episodes of heart
failure, ﬂuctuating renal dysfunction, and monomorphic
VT for which an ICD was implanted. In the past year, VT
episodes increased despite therapy with amiodarone at doses
of up to 600 mg daily. The patient was admitted for nearly
incessant slow VT with a CL of 430 ms, right bundle branch
block-like conﬁguration in lead V1, and rightward frontal
plane axis, consistent with an origin in the lateral LV scar.
His left ventricular ejection fraction was 20%, with LV end-
diastolic diameter of 7.3 cm. Serum creatinine was 1.07 mg/dL.KEYWORDS Ventricular tachycardia; Catheter ablation; Transcoronary etha-
nol ablation; Double valve replacement; Epicardial ablation
ABBREVIATIONS CL ¼ cycle length; ICD ¼ implantable cardioverter-
defibrillator; LV ¼ left ventricle; RF ¼ radiofrequency; RV ¼ right
ventricle; TCEA ¼ transcoronary ethanol ablation; VT ¼ ventricular
tachycardia (Heart Rhythm Case Reports 2015;1:163–166)
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sion computerized tomographic study showed a severely
dilated LV with a large region of myocardial scar in the
distribution of the distal left circumﬂex coronary artery
(Figure 1). Although he had a small paravalvular leak around
the aortic valve, hemodynamic function was deemed sat-
isfactory and not warranting repeat surgery. Warfarin was
held, and the patient was started on intravenous heparin. He
was subsequently taken to the electrophysiology laboratory.
Programmed ventricular stimulation from the right ven-
tricular (RV) apex with the patient under general anesthesia
induced 3 different morphologies of sustained monomorphic
VT (VT1–VT3), all of which had a shorter CL than the
documented VTs (Figure 2). None were bundle branch
reentry, and all appeared remote from the RV apex and
basal septum, where the His-bundle catheter was located.
Mechanical prosthetic aortic and mitral valves precluded
either a retrograde aortic or transseptal approach to the LV
endocardium. Epicardial access was attempted using a
subxiphoid percutaneous approach as described by Sosa
et al,1 and the pericardial space was entered beneath the RV.
There was no signiﬁcant pericardial bleeding or evidence of
inadvertent ventricular puncture. However, pericardial adhe-
sions from prior cardiac surgery limited catheter mapping to
the apical aspect of the LV. An electroanatomic voltage map
of the accessible epicardial surface was created using a
mapping system (CARTO 3, Biosense Webster, Diamond
Bar, CA) and a 3.5-mm irrigated-tip ablation catheter. An
extensive area of low bipolar voltage (o1.5 mV) consistent
with scar was present in the inferolateral LV apex extending
to the accessible mid-LV, consistent with perfusion imaging
(Figures 1 and 3). With pacing there was no left phrenic
nerve capture in the area. Monomorphic VT4 with CL of 410
ms, right bundle branch block-like conﬁguration in lead V1,
and right inferior frontal plane axis was induced with burst
pacing from the ablation catheter (Figure 2). It terminated
spontaneously. Substrate modiﬁcation of the scar was then
performed targeting regions of slow conduction evident as
late or fractionated potentials or stimulus-to-QRS delays
440 ms during pace-mapping.2 Radiofrequency (RF) abla-
tion was performed with power of 30–50 W aiming for a
minimum impedance drop of 10 Ω at each site in an attemptpen access article under the CC BY-NC-ND license
http://dx.doi.org/10.1016/j.hrcr.2015.02.007
Figure 2 Three fast ventricular tachycardia (VT) morphologies different
from the documented VT were induced from the right ventricular (RV) apex
(VT1–VT3). Another 3 VTs with different morphologies consistent with
origin in the lateral scar area, all with right bundle block-like morphology in
lead V1 and right frontal plane axis, were induced by pacing in the epicardial
scar area (VT5–VT6). VT6 was induced after the ﬁrst transcoronary ethanol
ablation (TCEA) and remained inducible.
KEY TEACHING POINTS
 After double valve replacement, an initial
epicardial approach to radiofrequency ablation for
treatment of ventricular tachycardia (VT) can be
considered when VT morphology is not suggestive
of a septal origin. However, percutaneous
epicardial access often is limited in patients with
prior cardiac surgery.
 Options for left ventricular (LV) access after double
valve replacement include direct percutaneous LV
puncture, percutaneous interventricular septal
puncture, and open chest surgical ablation.
 Transcoronary ethanol ablation can provide
effective treatment of recurrent VT for selected
patients when access to the LV endocardium and
epicardium is impeded.
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mA and 2-ms pulse width). During pace-mapping within the
scar, sustained monomorphic VT5 with a cycle length of 510
ms, right bundle branch block-like conﬁguration in lead V1,
and right superior frontal plane axis was induced (Figure 2).
It was initially hemodynamically tolerated, allowing activa-
tion and entrainment mapping. Earliest activation (10 ms
presystolic) was noted in the most posterior portion of the
accessible scar. However, activation was early over a broad
area. Entrainment mapping in that region produced con-
cealed fusion with a postpacing interval of 25 ms (Figure 3).
The VT did not terminate despite multiple RF applications
up to 120 seconds in duration. The epicardial unipolar
voltage map also showed extensive low unipolar voltage
(Figure 2).3 These ﬁndings suggested either an endocardialFigure 1 Tc-99m sestamibi rest myocardial perfusion single-photon emission co
large region of myocardial scar in the distribution of the distal left circumﬂex coron
large inferolateral area of low bipolar voltageo1.5 mV (middle panel) and unipo
INF ¼ inferior; LAT ¼ lateral; Uni ¼ unipolar voltage.or intramural VT origin with a broad epicardial breakout.
However, lack of accessibility to the endocardial LV
prompted a detailed bedside interdisciplinary discussion
among electrophysiologists, interventional cardiologists,
and cardiac surgeons about the next approach. Coronary
angiography was performed with the ablation cathetermputerized tomographic study showing a severely dilated left ventricle with a
ary artery (left panels). The epicardial voltage map (left lateral view) shows a
lar voltageo8.3 mV (right panel). ANT ¼ anterior; Bi ¼ bipolar voltage;
Figure 3 Entrainment mapping from the ablation catheter positioned in the inferolateral epicardial scar, where transcoronary ethanol ablation was
subsequently performed, showing concealed fusion with a postpacing interval of 25 ms. Abl ¼ ablation catheter; dist ¼ distal; prox ¼ proximal.
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activation and shortest postpacing intervals consistent with
the VT exit (Figure 4). Distal branches of a marginal branch
appeared to be supplying the scar (Online Supplementary
Material, Cine 1). The decision was made to perform TCEA.
An angioplasty balloon was inserted into 1 of the marginal
branches over the wire. The patient’s ongoing VT terminated
as soon as contrast was injected into the branch. The balloon
was positioned proximal to a bifurcation and inﬂated with
contrast to occlude the vessel. Ethanol 3 mL was then
injected down the vessel over several minutes. The balloon
remained inﬂated for 10 minutes (Online Supplementary
Material, Cine 2). Repeat angiography showed successful
occlusion of the targeted marginal branch (Online Supple-
mentary Material, Cine 3). Ventricular stimulation was
repeated from the epicardial LV. The previous VTs were
no longer inducible. However, another morphology of VT
(VT6) was induced (Figure 2). Therefore, a second small
marginal branch inferior to the previous vessel was cannu-
lated and injected with ethanol after balloon occlusion. VT6
remained inducible, however, and no further ablation was
performed.
During follow-up, the patient remained free of VT. His
device was subsequently upgraded to provide AV syn-
chrony and biventricular pacing, with subsequent re-explo-
ration for atrial lead dislodgment. He had no further
ICD shocks or documented VT, but he died 2 months
later from complications of sepsis, possibly related to device
infection.Figure 4 Overlay of coronary angiography and epicardial voltage map
showing distal branches of a marginal branch (arrows) supplying the
inferolateral area where the ablation catheter is located.Discussion
Catheter ablation of VT originating from the LV endocar-
dium typically is performed using an atrial transseptal or
retrograde aortic approach. However, neither approach is
feasible in the setting of mechanical aortic and mitral valves
given the high risk of catheter entrapment. When VT
morphology is not suggestive of a septal VT, an initial
epicardial approach for RF ablation can be considered. In our
experience, percutaneous epicardial access in patients with
prior cardiac surgery is successful in only about 30% ofpatients.4 Tschabrunn et al5 reported obtaining access that
was limited but allowed for ablation in 8 patients with prior
surgery for valvular heart disease. As in our case, extensive
mapping was limited by adhesions. A surgical subxiphoid
approach that allows blunt dissection of adhesions under
direct vision has been performed successfully and offers an
alternative.6
In our case, epicardial ablation abolished some of the
inducible VTs, but others remained likely because of
intramural, endocardial, or epicardial substrate that was out
of reach beneath adhesions. Hsieh et al7 reported 2 cases in
which direct percutaneous LV puncture and catheter ablation
were used effectively to treat scar-related VT in patients with
prosthetic aortic and mitral valves. Hemorrhage into the left
pleural space occurred in the ﬁrst case and was prevented in
the second by using a minithoracotomy and pursestring ties
to control bleeding from the LV puncture site. Vaseghi et al8
reported successful percutaneous interventricular septal
puncture to gain access to the LV endocardium for VT
ablation in a patient with dual mechanical valve replacement.
Open chest surgical ablation is also an option but was not
Heart Rhythm Case Reports, Vol 1, No 4, July 2015166selected in our patient because of his comorbidities and
absence of need for surgical revision of his valves.9
TCEA is an option for selected patients when endocardial
and epicardial ablation have failed.10 It can provide effective
termination of VT storm and reduce the number of arrhyth-
mic episodes.11 Our patient was challenging because routine
endocardial LV access was not possible, epicardial access
was hampered by adhesions from prior cardiac surgery, and
comorbidities increased the risks of surgical cryoablation and
transventricular access. The case demonstrates the feasibility
of TCEA for treatment of VT when access to the LV
endocardium and epicardium is impeded.
Appendix
Supplementary data
Supplementary material cited in this article is available
online at http://dx.doi.org/10.1016/j.hrcr.2015.02.007.References
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